Teradyne (TER) Cost of Revenue (2016 - 2025)
Historic Cost of Revenue for Teradyne (TER) over the last 17 years, with Q3 2025 value amounting to $319.9 million.
- Teradyne's Cost of Revenue rose 635.67% to $319.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 157.54%. This contributed to the annual value of $1.2 billion for FY2024, which is 275.57% up from last year.
- According to the latest figures from Q3 2025, Teradyne's Cost of Revenue is $319.9 million, which was up 635.67% from $278.8 million recorded in Q2 2025.
- Teradyne's Cost of Revenue's 5-year high stood at $438.7 million during Q3 2021, with a 5-year trough of $260.5 million in Q1 2024.
- Its 5-year average for Cost of Revenue is $313.9 million, with a median of $305.4 million in 2023.
- In the last 5 years, Teradyne's Cost of Revenue skyrocketed by 1948.62% in 2021 and then plummeted by 2378.68% in 2022.
- Teradyne's Cost of Revenue (Quarter) stood at $358.0 million in 2021, then fell by 13.02% to $311.4 million in 2022, then decreased by 6.53% to $291.1 million in 2023, then rose by 5.0% to $305.6 million in 2024, then grew by 4.68% to $319.9 million in 2025.
- Its last three reported values are $319.9 million in Q3 2025, $278.8 million for Q2 2025, and $270.3 million during Q1 2025.